Gemcitabine Induced Cardiomyopathy
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2019)
Abstract
Gemcitabine is a pyrimidine antimetabolite that inhibits DNA synthesis and is used commonly as an adjuvant chemotherapy agent for resectable pancreatic cancer as a single agent. Gemcitabine is generally not considered as a cardiotoxic agent and very few case reports exist in literature about
MoreTranslated text
Key words
gemcitabine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined